abstract |
A method of preventing and treating abnormal metabolic bone disorders in a postmenopausal or oophorectomized woman is disclosed, which comprises administering to said an effective amount of exemestane or 17-hydro-exemestane, alone or in combination with additional therapeutic agents. |